Fermer le menu


Member of Lyonbiopole


NETRI is an industrial start-up developing innovative technologies for the pharmaceutical industry. Everything we do, we believe in challenging the way we discover new treatments. We use neural activity at the network level to translate mode of action of any drugs. We design, manufacture and sell standardized neuro organsoids-on-chip.

Our patented neuro organsoids-on-chip technologies allow the creation of standardized and predictive human in vitro models. This allows to anticipate the efficacy of an innovative treatment, to accelerate preclinical research phases, and to reposition compounds on new indications, while limiting animal testing. The use of human neural circuits coupled with multiple cell types opens the way to more personalized medicine as well as faster and more relevant diagnostics. Our current application areas include neurological disorders, dermo-cosmetics and toxicology.


Strategic application domain: Medical Technologies

Application market: Dermatology & Cosmetology, Neurology & Mental Health Disorders, Oncology

Type of activity: CRO - Tools - R&D platform, Technology provider, Therapeutics, Pharma or Biotech

Technologies: Analytical methods, diagnostic & Pronostic markers, Microfluidic, Screening methods or services

Created on june 11th, 2018 - 27 employees



Batiment DomiLyon, 321 avenue Jean Jaurès 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.